Log In
Print this Print this

XOMA 358

  Manage Alerts
Collapse Summary General Information
Company Xoma Corp.
DescriptionHuman negative allosteric IgG2 mAb that binds to insulin receptor (INSR)
Molecular Target Insulin receptor (INSR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today